Constitutive and tumor necrosis factor-α-induced activation of nuclear factor-κB in adenomyosis and its inhibition by andrographolide
article
OA: closed
CC0
⤵ 49 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (94)
- Adenomyosis via openalex
- Adenomyosis as a disorder of the early and late human reproductive period via openalex
- Adenomyosis: epidemiological factors via openalex
- Adenomyosis in endometriosis – prevalence and impact on fertility. Evidence from magnetic resonance imaging via openalex
- Adenomyosis in endometriosis—prevalence and impact on fertility. Evidence from magnetic resonance imaging via openalex
- Agents Blocking the Nuclear Factor-κB Pathway Are Effective Inhibitors of Endometriosis in an in vivo Experimental Model via openalex
- Application of the nuclear factor-κB inhibitor BAY 11-7085 for the treatment of endometriosis: an in vitro study via openalex
- Clinical significance of adenomyosis. via openalex
- Combating endometriosis by blocking proteasome and nuclear factor- B pathways via openalex
- Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis via openalex
- Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis via openalex
- Dysmenorrhea: Risk Factors in Women with Endometriosis via openalex
- Effect of menstrual cycle and hormonal treatment on ki-67 and bcl-2 expression and adenomyosis via openalex
- Effects of angiogenesis inhibitor TNP-470 on the development of uterine adenomyosis in mice via openalex
- Elevated immunoreactivity to tissue factor and its association with dysmenorrhea severity and the amount of menses in adenomyosis via openalex
- Endometrial Angiogenesis, Vascular Maturation, and Lymphangiogenesis via openalex
- Expression of Cyclooxygenase-2 and Matrix Metalloproteinase-2 in Adenomyosis and Endometrial Polyps and its Correlation With Angiogenesis via openalex
- Expression of interleukin-8 and monocyte chemotactic protein-1 in adenomyosis via openalex
- Expression of interleukin-8 receptors in patients with adenomyosis via openalex
- Expression of Vascular Endothelial Growth Factor (VEGF), Hypoxia Inducible Factor-1α (HIF-1α), and Microvessel Density in Endometrial Tissue in Women With Adenomyosis via openalex
- <i>Endometriosis and Tissue Factor</i> via openalex
- Immunoreactivity of oxytocin receptor and transient receptor potential vanilloid type 1 and its correlation with dysmenorrhea in adenomyosis via openalex
- Increased Activation of the PI3K/AKT Pathway Compromises Decidualization of Stromal Cells from Endometriosis via openalex
- Increased microvessel density in adenomyosis uteri via openalex
- Involvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis via openalex
- Is adenomyosis an immune disease? via openalex
- Levo-Tetrahydropalmatine Retards the Growth of Ectopic Endometrial Implants and Alleviates Generalized Hyperalgesia in Experimentally Induced Endometriosis in Rats via openalex
- Matrix Metalloproteinase-2 and -9 Expression Correlated with Angiogenesis in Human Adenomyosis via openalex
- Mechanical Stretch Stimulates Interleukin-8 Production in Endometrial Stromal Cells: Possible Implications in Endometrium-Related Events via openalex
- Medical and surgical management of adenomyosis via openalex
- Morphometric evaluation of stromal vascularization in the endometrium in adenomyosis via openalex
- Non‐Specificity of Symptoms Related to Adenomyosis via openalex
- Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis via openalex
- Nuclear Factor-κB (NF-κB): An Unsuspected Major Culprit in the Pathogenesis of Endometriosis That Is Still at Large? via openalex
- Prostaglandin E <sub>2</sub> : the master of endometriosis? via openalex
- Role of cytokines in endometriosis via openalex
- The pathophysiology of uterine adenomyosis: an update via openalex
- Therapeutic potential of andrographolide for treating endometriosis via openalex
- The Role of Cytokines in Endometriosis* via openalex
- Uterotubal transport disorder in adenomyosis and endometriosis—a cause for infertility via openalex
- Vascular endothelial growth factor and endometriotic angiogenesis via openalex
- W2038354928 via openalex
- W2054531607 via openalex
- W2036411073 via openalex
- W2055792439 via openalex
- W2056686776 via openalex
- W2033232788 via openalex
- W2031089158 via openalex
- W2058170926 via openalex
- W2058218898 via openalex
- W2029602474 via openalex
- W2029599962 via openalex
- W2064892294 via openalex
- W2028823965 via openalex
- W2089270158 via openalex
- W2025476693 via openalex
- W2091815717 via openalex
- W2093457368 via openalex
- W2023917273 via openalex
- W2019291960 via openalex
- W2100388532 via openalex
- W1491294744 via openalex
- W2016686699 via openalex
- W2105497865 via openalex
- W2107277218 via openalex
- W2006791751 via openalex
- W2002708977 via openalex
- W1997359763 via openalex
- W2116889376 via openalex
- W2121306814 via openalex
- W1982173676 via openalex
- W1972901014 via openalex
- W2136200385 via openalex
- W2148226187 via openalex
- W1969761972 via openalex
- W1966243693 via openalex
- W1965769436 via openalex
- W2158438088 via openalex
- W1825540737 via openalex
- W2159973565 via openalex
- W1600879783 via openalex
- W2185288208 via openalex
- W2314325548 via openalex
- W2315049322 via openalex
- W1548219170 via openalex
- W2406818453 via openalex
- W1526636100 via openalex
- W1506446734 via openalex
- W4229880569 via openalex
- W4241216156 via openalex
- W6631394792 via openalex
- W6635565826 via openalex
- W2041140906 via openalex
- W6823113895 via openalex
Cited by (49)
- Shared Biology Underlying Benign Endometrial Diseases and Endometrial Cancer: Current Knowledge and Future Prospectives 2026
- Drug development for adenomyosis based on pathophysiology 2025
- Metabolic Reprogramming Mediates Chronic Stress–Induced Immune Dysregulation in Endometriosis 2025
- Progressively Diminished Prostaglandin E2 Signaling in Concordance with Increasing Fibrosis in Ectopic Endometrium 2024
- Association between Uterine Adenomyosis and Infertility: Role of Axonemal Alteration in Apical Endometria 2024
- Vitamin D evaluation in adenomyosis: A retrospective cross-sectional study 2024
- Chronic Stress Blocks the Endometriosis Immune Response by Metabolic Reprogramming 2023
- Extracellular vesicles contribute to EMT in adenomyosis by inducing macrophage polarization 2023
- The Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis 2023
- Hypercoagulability in women with adenomyosis who experience heavy menstrual bleeding 2023
- Pathogenesis of Human Adenomyosis: Current Understanding and Its Association with Infertility 2022
- The Menstrual Endometrium: From Physiology to Future Treatments 2022
- Overexpression of Human Estrogen Biosynthetic Enzyme Hydroxysteroid (17beta) Dehydrogenase Type 1 Induces Adenomyosis-like Phenotype in Transgenic Mice 2022
- How does the extent of fibrosis in adenomyosis lesions contribute to heavy menstrual bleeding? 2022
- Melatonin improves pregnancy outcomes in adenomyosis mice by restoring endometrial receptivity via NF-κB/apoptosis signaling 2022
- Relationship between MUC17 Gene Polymorphisms and Endometriosis in Central Plains Chinese Women 2022
- Uterine Anteroposterior Diameter Measured by Transvaginal Sonography is a Predictor for Dysmenorrhea in Patients With and Without Endometriosis 2022
- Cracking the enigma of adenomyosis: an update on its pathogenesis and pathophysiology 2022
- Molecular Targets for Nonhormonal Treatment Based on a Multistep Process of Adenomyosis Development 2022
- Celecoxib reduces inflammation and angiogenesis in mice with adenomyosis. 2021
- The roles and functions of macrophages in endometriosis 2021
- The Role of Abnormal Uterine Junction Zone in the Occurrence and Development of Adenomyosis 2021
- Activation of the cGAS–STING signaling pathway in adenomyosis patients 2021
- The new application of mifepristone in the relief of adenomyosis-caused dysmenorrhea 2020
- Adenomyosis: Mechanisms and Pathogenesis 2020
- Immunological changes associated with adenomyosis: a systematic review 2020
- Perioperative Intervention by β-Blockade and NF-κB Suppression Reduces the Recurrence Risk of Endometriosis in Mice Due to Incomplete Excision 2019
- Mechanisms Underlying Adenomyosis-Related Fibrogenesis 2019
- Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review 2019
- Pathogenesis of uterine adenomyosis: invagination or metaplasia? 2018
- “Recurrent multiple cerebral infarctions related to the progression of adenomyosis: a case report” 2018
- Rhein ameliorates adenomyosis by inhibiting NF-κB and β-Catenin signaling pathway 2017
- Pathogenesis of adenomyosis: an update on molecular mechanisms 2017
- Downregulation of DNA methyltransferase 3 alpha promotes cell proliferation and invasion of ectopic endometrial stromal cells in adenomyosis 2016
- Expression of Inflammatory and Neurogenic Mediators in Adenomyosis: A Pathogenetic Role 2016
- Increased expression of nuclear factor kappa-B p65 subunit in adenomyosis 2016
- Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis 2016
- Update of recent studies of adenomyosis-associated dysmenorrhea 2016
- Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence 2016
- Current and Future Medical Treatment of Adenomyosis 2016
- Adénomyose et implantation : mise au point 2015
- Increased expression of p21-activated kinase 4 in adenomyosis and its regulation of matrix metalloproteinase-2 and -9 in endometrial cells 2015
- The Endometrium in Adenomyosis 2015
- A pilot study on the use of andrographolide to treat symptomatic adenomyosis 2014
- Human Adenomyosis Endometrium Stromal Cells Secreting More Nerve Growth Factor 2014
- Possible Loss of GABAergic Inhibition in Mice With Induced Adenomyosis and Treatment With Epigallocatechin-3-Gallate Attenuates the Loss With Improved Hyperalgesia 2014
- Resolvins RvD1 and 17(R)-RvD1 alleviate signs of inflammation in a rat model of endometriosis 2014
- Structural and molecular features of the endomyometrium in endometriosis and adenomyosis 2013
- The Endometrium in Adenomyosis 2012
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:18:59.468224+00:00
License: CC0
· commercial use OK